AI 기반 수술 모니터 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the aI-Powered surgical monitor market size is projected to expand from USD 248.20 million in 2025 and USD 283.62 million in 2026 to USD 587.29 million by 2031, registering a CAGR of 15.67% between 2026 to 2031.

This report is Segmented by Product Type (Standalone, Integrated Visualization, or Integration, AI-Guidance), Display (LED LCD, OLED, Mini-LED/MicroLED), Resolution (HD, Full HD, 4K, 8K), Application (Laparoscopy, Endoscopy, Arthroscopy, ENT, Neurosurgery, Orthopedic, CV Surgery, Robotic), End User (Hospitals, Ascs, Clinics), and Geography (North America, Europe, APAC, MEA, South America). Value in USD.

Global AI-Powered Surgical Monitor Market Trends and Insights

Rising Minimally Invasive and Image-Guided Surgery Volumes

The AI-powered surgical monitor market is benefiting from the structural rise of minimally invasive and image-guided surgery because the surgeon's operative field is viewed through a monitor from start to finish. This makes brightness, contrast, latency, and image stability part of clinical workflow rather than secondary hardware features. MedPAC reported that U.S. ambulatory surgical centers performed 6.4 million surgical procedures in 2024 across 6,436 facilities, while procedure volume per 1,000 Medicare beneficiaries increased 3.4% year over year, which shows the procedural base supporting the AI-powered surgical monitor market is still broadening. A January 2026 study in Frontiers in Surgery found that AI-assisted object detection increased the share of surgeons identifying critical lymph nodes within 2 seconds from 4.67% to 42.99%, which links screen-based AI support to measurable intraoperative performance. That type of outcome linkage is making procurement discussions more clinical and less equipment-centered, which supports faster replacement decisions in academic hospitals and advanced surgical centers. As a result, the AI-powered surgical monitor market is gaining from both rising case volumes and growing belief that visualization quality can directly affect surgical consistency.

Embedded AI for Intraoperative Detection and Workflow Automation

The AI-powered surgical monitor market is also moving forward because embedded AI has shifted from single-task experiments toward multi-task systems that can run at clinically usable speeds during live surgery. In October 2025, Frontiers in Oncology reported that the Intelligent Surgical Assistant for laparoscopic liver surgery reached 89% instrument and organ recognition accuracy at 19.2 fps and delivered an AP50 of 95.2% on an external validation cohort, which supports the move toward real-time on-screen assistance. This matters for the AI-powered surgical monitor market because edge-based compute reduces dependence on cloud bandwidth, which allows hospitals to adopt advanced display systems without waiting for a full IT overhaul. The monitor is therefore becoming a compute endpoint as well as a display surface, and that is changing how hospitals define technical specifications. Procurement teams are beginning to ask for support for overlay execution, data handling, and software extensibility, in addition to conventional display measures. That shift raises the long-term value of platforms that can host future algorithms, which strengthens the commercial position of vendors with scalable hardware and software architectures.

High Capital Cost and Complex OR Integration

The AI-powered surgical monitor market still faces slower conversion in many health systems because a fully integrated visualization suite with AI compute and OR connectivity can carry a very high upfront cost. This challenge is amplified when hybrid operating rooms require support for multiple imaging modalities, robotics feeds, and routing systems inside one environment. A July 2025 paper in Frontiers in Digital Health found that 75% of surveyed medical device manufacturers cited inadequate human-machine interface requirements in current interoperability standards, while 87.5% would not share risk-management documentation with unknown network participants, which shows how governance and liability concerns add to technical complexity. The result is that the AI-powered surgical monitor market does not operate like a simple replacement market, because large systems often come with long service obligations and lengthy committee review. Vendors need stronger proof on operating efficiency, complication reduction, or total episode economics to displace installed platforms. Until that proof becomes more consistent across procedures and health systems, capital discipline will continue to slow adoption in facilities with stretched budgets.

Other drivers and restraints analyzed in the detailed report include:

1. ASC Migration Lifts Demand for Compact Visualization Suites
2. Regulatory Legitimization of Real-Time AI Video Augmentation
3. OR Video Governance and Cybersecurity Burden

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Integrated AI Visualization Systems held 70.02% of the AI-powered surgical monitor market size in 2025, which shows that hospitals still prefer consolidated architectures that reduce vendor coordination and centralize service obligations. In the AI-powered surgical monitor market, these systems are favored because imaging management, AI processing, and multi-source routing can be delivered through a single platform rather than separate hardware layers. Olympus launched VISERA ELITE III in the United States in March 2026, and the platform combined True 4K and 3D imaging, Narrow Band Imaging, fluorescence-guided surgery in Magenta Mode, continuous auto-focus, and integration with Olympus VaultStream and LiveStream portals, which reflects how integrated systems are broadening their software role. The AI-powered surgical monitor market continues to reward this format because procurement teams often view a unified stack as lower risk when surgical uptime and service accountability matter. The installed base in larger hospitals also supports integrated platforms because these facilities are more likely to run multi-specialty ORs that need a common imaging backbone.

AI-enabled OR Integration Display Platforms are forecast to grow at 16.05% CAGR through 2031, making them the fastest-expanding product category in the AI-powered surgical monitor industry because hybrid OR builds increasingly need one display fabric to handle multiple live data sources. In the AI-powered surgical monitor market, this category is gaining because robotic feeds, navigation inputs, and imaging overlays must coexist without forcing separate screens and duplicate routing hardware. Standalone AI-enabled monitors still serve smaller ASCs and specialty clinics where full integration is too costly, and AI-guidance display platforms remain the frontier category where real-time overlays and robotic interfaces are most tightly linked. Across the AI-powered surgical monitor industry, baseline requirements such as IEC 60601 electrical safety and ISO 13485 quality management continue to shape vendor qualification before feature differentiation becomes relevant.

LED-backlit LCD panels accounted for 56.46% of revenue in 2025, which reflects the large installed base, lower acquisition cost, and broad compatibility that still shape the AI-powered surgical monitor market. Many hospitals continue to rely on LED-backlit LCD systems because they fit existing video chains and meet everyday surgical needs without the premium pricing attached to newer emissive technologies. The AI-powered surgical monitor market still gives LED an advantage in replacement cycles where facilities prioritize reliability, service familiarity, and budget discipline over top-end contrast performance. Even so, the technology ceiling of conventional LCD becomes more visible when AI overlays, fluorescence signals, and dark-field imaging are used in the same procedure. This is why the AI-powered surgical monitor market is steadily creating room for premium tiers rather than removing the volume base of LED systems all at once.

OLED is projected to grow at 15.47% CAGR through 2031 because per-pixel light control supports fluorescence-guided surgery and tissue-oxygenation overlays that depend on strong contrast separation. Hypervision Surgical's FDA-cleared HYPERSNAP system uses hyperspectral imaging with AI-powered analytics and operates at more than 60 fps, which underlines the type of demanding image environment that benefits from higher display fidelity. EIZO launched the CuratOR EX3245H in April 2026 with a Mini-LED backlight, more than 2,000 local dimming zones, a 1,000,000:1 contrast ratio, and IP45 front-panel protection, while LG introduced a 31.5-inch 4K Mini-LED surgical monitor in November 2025 with automated failover input switching and workflow presets, which together show how Mini-LED is being positioned as a practical bridge between standard LED and premium OLED in the AI-powered surgical monitor market. As a result, the AI-powered surgical monitor market is developing a three-tier technology ladder where LED retains scale, Mini-LED broadens mid-premium demand, and OLED addresses the most image-sensitive procedures.

Geography Analysis

North America held 43.56% of the AI-powered surgical monitor market share in 2025, which kept it as the largest regional contributor because it combines advanced robotic surgery infrastructure, a deep outpatient base, and early regulatory acceptance of intraoperative AI. The AI-powered surgical monitor market in the region is supported by the FDA's new product code for AI and machine learning based real-time video augmentation, first applied to Hypervision Surgical's HYPERSNAP clearance in July 2025. MedPAC reported that the United States had 6,436 ASCs and 6.4 million ASC procedures in 2024, which reinforces the scale of the outpatient channel that can accelerate visualization upgrades. Canada adds demand through large hospital systems, although public procurement cycles can extend refresh timing. Mexico remains more concentrated in private hospital networks in major cities, which favors targeted premium deployments rather than broad national rollout.

Europe remains a major center for the AI-powered surgical monitor market because robotic surgery volumes are high and regulatory compliance standards are strict enough to favor vendors with deeper quality and documentation infrastructure. Intuitive said in July 2025 that da Vinci 5 received CE Mark, and the company also reported that European da Vinci procedures grew 21% in 2025 and exceeded 1.1 million, which indicates strong regional procedure depth for high-end visualization demand. KARL STORZ stated in November 2025 that its OR1 platform was installed in more than 12,000 ORs globally and that the company was advancing SurgicalAIHubGermany with research partners, which shows how established European vendors are deepening software capabilities around a large installed base. The AI-powered surgical monitor market in the region, therefore, combines strong clinical demand with a compliance environment that raises entry barriers and supports consolidation around experienced vendors.

Asia-Pacific is projected to expand at 17.89% CAGR in the AI-powered surgical monitor market size through 2031, making it the fastest-growing regional arena as Japan, China, South Korea, and India move along different but complementary adoption paths. The AI-powered surgical monitor market in Japan is benefiting from PMDA-backed momentum for intraoperative AI and from clinical demonstrations that show these tools can operate in live surgical settings. NEDO announced in March 2026 that it had developed a surgery-focused generative AI system and demonstrated clinical-grade intraoperative dialogue performance during live gastric cancer surgery at Keio University Hospital, which strengthens Japan's role as a reference market for AI-supported surgical visualization. Medtronic launched the Touch Surgery ecosystem in Japan in April 2026 for use with the Hugo robotic platform and conventional laparoscopic setups, which signals that suppliers are treating Japan as an important commercialization base for AI-enabled surgical video workflows. China adds scale through hospital modernization and demand for 4K imaging in tier-1 networks, while India contributes through corporate hospital expansion and partnership-led technology adoption. South Korea adds another layer of growth because its domestic robotics ecosystem creates demand for compatible visualization and overlay systems across newer surgical platforms.

1. Barco NV
2. Brain Lab
3. Caresyntax Corp.
4. Conmed
5. EIZO Corporation
6. FSN Medical Technologies
7. FUJIFILM
8. Getinge
9. Hypervision Surgical Ltd.
10. Intuitive Surgical, Inc.
11. Karl Storz
12. Koninklijke Philips
13. LG Electronics Inc.
14. Medtronic
15. NDS Surgical Imaging
16. Novanta Inc.
17. Olympus
18. Proprio, Inc.
19. Richard Wolf
20. Siemens Healthineers
21. Sony Group
22. STERIS

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Minimally Invasive and Image-Guided Surgery Volumes
  • 4.2.2 4K And 3D Upgrade Cycle in Hybrid Operating Rooms
  • 4.2.3 ASC Migration Lifts Demand for Compact Visualization Suites
  • 4.2.4 Embedded AI For Intraoperative Detection and Workflow Automation
  • 4.2.5 Regulatory Legitimization of Real-Time AI Video Augmentation
  • 4.2.6 Need For Multi-Modal Overlays Across Robotics and Navigation
• 4.3 Market Restraints
  • 4.3.1 High Capital Cost and Complex OR Integration
  • 4.3.2 Legacy Interoperability Across Towers and Video Protocols
  • 4.3.3 Liability and Reimbursement Ambiguity for AI-Guided Decisions
  • 4.3.4 OR Video Governance and Cybersecurity Burden
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Industry Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Product Type
  • 5.1.1 AI-enabled Standalone Surgical Monitors
  • 5.1.2 Integrated AI Visualization Systems
  • 5.1.3 AI-enabled OR Integration Display Platforms
  • 5.1.4 AI-guidance Display Platforms
• 5.2 By Display Technology
  • 5.2.1 LED-backlit LCD
  • 5.2.2 OLED
  • 5.2.3 Mini-LED and MicroLED
• 5.3 By Resolution
  • 5.3.1 HD
  • 5.3.2 Full HD
  • 5.3.3 4K Ultra HD
  • 5.3.4 8K Ultra HD
• 5.4 By Application
  • 5.4.1 Laparoscopy
  • 5.4.2 Endoscopy
  • 5.4.3 Arthroscopy
  • 5.4.4 ENT Surgery
  • 5.4.5 Neurosurgery
  • 5.4.6 Orthopedic Surgery
  • 5.4.7 Cardiovascular Surgery
  • 5.4.8 Robotic-assisted Surgery
• 5.5 By End User
  • 5.5.1 Hospitals
  • 5.5.2 Ambulatory Surgical Centers
  • 5.5.3 Specialty Clinics
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East & Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East & Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
  • 6.3.1 Barco NV
  • 6.3.2 Brainlab AG
  • 6.3.3 Caresyntax Corp.
  • 6.3.4 CONMED Corporation
  • 6.3.5 EIZO Corporation
  • 6.3.6 FSN Medical Technologies
  • 6.3.7 FUJIFILM Holdings Corporation
  • 6.3.8 Getinge AB
  • 6.3.9 Hypervision Surgical Ltd.
  • 6.3.10 Intuitive Surgical, Inc.
  • 6.3.11 KARL STORZ SE & Co. KG
  • 6.3.12 Koninklijke Philips N.V.
  • 6.3.13 LG Electronics Inc.
  • 6.3.14 Medtronic plc
  • 6.3.15 NDS Surgical Imaging
  • 6.3.16 Novanta Inc.
  • 6.3.17 Olympus Corporation
  • 6.3.18 Proprio, Inc.
  • 6.3.19 Richard Wolf GmbH
  • 6.3.20 Siemens Healthineers AG
  • 6.3.21 Sony Group Corporation
  • 6.3.22 STERIS plc

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment